Salute e Benessere

The Clouds Give Way as Ariana Grande Debuts Her Newest Fragrance, Cloud Pink

The launch of Cloud Pink introduces a new chapter to the multihyphenate's iconic collection. Ethereal and modern, Cloud Pink is inspired by Ariana's magnetic optimism and confidence. The elevated campaign is perhaps her most personal yet, brilliantly showcasing Grande's evolution as an artist and woman. The launch of Cloud Pink introduces a new chapter to the multihyphenate's iconic collection. Ethereal and modern, Cloud Pink is inspired by Ariana's magnetic optimism and confidence. The...
PR Newswire
10/08/2023

Digital Biomarkers Market to Reach $14.7 Billion by 2032, Globally, by 2032 at a…

Request Sample of the Report on Digital Biomarkers Market Forecast 2032- Allied Market Research- https://www.alliedmarketresearch.com/request-sample/132906 Request Sample of the Report on Digital Biomarkers Market Forecast 2032- Allied Market Research-https://www.alliedmarketresearch.com/request-sample/132906 Digital biomarkers are quantifiable, unwavering physiological, behavioral, or environmental data that is gathered using digital platforms or equipment. These biomarkers come...
PR Newswire
10/08/2023

New UK partnership and research fund aims to tackle infectious diseases

Liverpool School of Tropical Medicine (LSTM) and self-funded charitable medical research organisation, LifeArc, are partnering to launch a new Translational Development Fund to help tackle infectious diseases.LifeArc will invest £2.7 million into the fund, which will support the progression of new technologies and treatments for emerging viral threats and neglected tropical diseases.LifeArc will also join the LSTM-led Infection Innovation Consortium: iiCON, making its platform to...
Nasdaq GlobeNewswire
10/08/2023

Nevro announces launch of HFX Connect™ in Europe and CE marking of expanded…

HFX Connect will be available to both new Omnia™ patients and those already implanted, allowing healthcare teams to remotely optimize patients with 35 pre-programmed customisable treatment plans, and seven times the amount originally available. HFX Connect will be available to both new Omnia™ patients and those already implanted, allowing healthcare teams to remotely optimize patients with 35 pre-programmed customisable treatment plans, and seven times the amount originally available. Dr...
PR Newswire
10/08/2023

Genmed appoints Jolene Rayner as chief executive officer

Working in close partnership with NHS Trusts, Jolene has been instrumental in bringing to market new managed services involving clinical disciplines such as pathology, renal, surgery and endoscopy. This has seen Genmed's revenues increase from just over £5 million a decade ago when she joined to over £100 million today. Working in close partnership with NHS Trusts, Jolene has been instrumental in bringing to market new managed services involving clinical disciplines such as pathology, renal,...
PR Newswire
10/08/2023

XNK Therapeutics enters into agreement with US-based biotechnology company

For more information, please contact: Johan Liwing, CEO, XNK Therapeutics Tel: +46 706 70 36 75E-mail: johan.liwing@xnktherapeutics.com For more information, please contact: Johan Liwing, CEO, XNK TherapeuticsTel: +46 706 70 36 75 E-mail:johan.liwing@xnktherapeutics.com About XNK Therapeutics AB XNK Therapeutics is a clinical stage immunotherapy company focused on bringing new and more effective treatments to cancer patients. The company is at the forefront of autologous NK...
PR Newswire
10/08/2023

Novo Nordisk's sales increased by 29% in Danish kroner and by 30% at constant…

Financial report for the period 1 January 2023 to 30 June 2023, 10 August 2023 Operating profit increased by 30% in Danish kroner and by 32% at constant exchange rates (CER) to DKK 48.9 billion.Sales in North America Operations increased by 45% in Danish kroner (44% at CER). Sales in International Operations increased by 14% in...
Nasdaq GlobeNewswire
10/08/2023

Press Release Biocartis Group NV: Biocartis Partners with Lilly to Explore…

PRESS RELEASE: 10 August 2023 , 07:00 CESTBiocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla™ PlatformMechelen, Belgium, 2023- Biocartis Group NV (the 'Company' or 'Biocartis'), a global innovative molecular diagnostics company (Euronext Brussels: BCART) today announced that they have entered into a new post-commercial collaboration program with Lilly, a global pharmaceutical company. This program...
Nasdaq GlobeNewswire
10/08/2023

Addex Reports 2023 Half Year and Second Quarter Financial Results and Provides…

ADX71149 Phase 2 epilepsy clinical study Cohort 2 continues recruiting following the Independent Interim Review Committee (IRC) recommendationIndivior GABAB PAM collaboration extended to June 2024 with CHF 2.7 million of committed research fundingCHF 7.2M ($8.0M) of cash and cash equivalents at June 30 , 2023 Ad Hoc Announcement Pursuant to Art. 53 LRGeneva, Switzerland, August 10 , 2023-Addex Therapeutics(SIX:...
Nasdaq GlobeNewswire
10/08/2023

Gates Foundation Selects Nearly 50 Global Health and Development Projects That…

Responsible and safe use of AI-driven LLM technology has the potential to help solve some of the world's toughest health and development challenges. However, for these models to be useful in LMICs, researchers in LMICs need to participate in the design, application, and testing of this technology as it rapidly evolves. A robust evidence base will fill gaps in access and our knowledge about the application of such tools to address problems across LMICs in an equitable way. Responsible and...
PR Newswire
10/08/2023

Generalized Myasthenia Gravis Market is Expected to Expand by 2032, Assesses…

Key Takeaways from the Generalized Myasthenia Gravis Market Report Key Takeaways from the Generalized Myasthenia Gravis Market Report Discover which therapies are expected to grab the major generalized myasthenia gravis market share @Generalized Myasthenia Gravis Market Report Generalized Myasthenia Gravis Overview Generalized myasthenia gravis is a chronic autoimmune disorder that affects the neuromuscular junction, leading to muscle weakness and fatigue. This condition...
PR Newswire
09/08/2023

Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises…

"Our focused execution delivered strong momentum across all three key growth drivers of our commercial business, with significant demand for Xywav, Epidiolex and Rylaze. We remain confident that our oxybate franchise will reach $2 billion in 2025, underpinned by the durability and growth of low-sodium Xywav. We've achieved another quarter of double-digit, year-over-year growth of Epidiolex, as we unleash its blockbuster potential through in-person engagement, compelling data and ongoing…
PR Newswire
09/08/2023

Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth's…

NEWS RELEASE 9AUGUST2023 , 4PM ET / 22:00 CET CignaExpands Commercial and Medicare Advantage Coverageto Include Mdxhealth's Select mdxfor Prostate Cancer TestExpansion of coverage with Cigna now includesfull menu of Company's precision diagnostic prostatecancer tests, representingmore than 15 million lives under coverageIRVINE, CA, and HERSTAL, BELGIUM– August 9, 2023 – MDxHealth SA...
Nasdaq GlobeNewswire
09/08/2023

Flow Cytometry Market worth $7.0 billion | MarketsandMarkets

The growth of this market is driven by the increasing prevalence of chronic diseases and increasing funding for research. Moreover, the launch of novel products in the market by key market players and increased use of flow cytometry in clinical research & diagnostics, such as HIV/AIDS Monitoring, organ transplantation, and cancer diagnostics, are some of the elements propelling the growth of the market. The growth of this market is driven by the increasing prevalence of chronic diseases…
PR Newswire
09/08/2023

Generic Drugs Market is Projected To Reach USD 835.7 Billion By 2032, Growing at…

Major Factors Driving The Growth Of Generic Drugs Market are Major Factors Driving The Growth Of Generic Drugs Market are The market for generic medications is expanding significantly, partly as a result of factors including the patents for many branded medications expiring, mounting demand to lower healthcare costs, and the rising incidence of chronic diseases globally. Generic medications provide more economical substitutes for their brand-name equivalents, increasing access to and...
PR Newswire
09/08/2023

Since 2011, RNA therapeutics developers have secured investments worth more than…

RNA therapies have emerged as a promising treatment modality, with the potential to target and alter genes, modulate protein functions and broaden the range of druggable targets, thereby paving way for new avenues in disease diagnosis and treatment. With rise in government initiatives for early commercialization of pipeline therapies and active involvement of investors, we anticipate a variety of novel RNA based therapeutics to be developed, presenting lucrative opportunities for both short- and…
PR Newswire
09/08/2023

AIM ImmunoTech to Discuss Second Quarter 2023 Financial Results on August 15…

AIM ImmunoTech Inc. (NYSE American: AIM)(“AIM” or the “Company”) announced today that management will host aconference call and webcastto discuss the Company's Q2 2023 operational and financial results on Tuesday, August 15, 2023 at 8:30 AM ET.The call will be hosted by members of AIM's leadership team, Thomas K. Equels, Chief Executive Officer and Christopher McAleer, PhD, Scientific Officer. Interested participants and investors may access the conference call by dialing (877)...
Nasdaq GlobeNewswire
09/08/2023

AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive…

Cutting-edge AI/machine learning technology with validation in humans for early diagnosis of lung cancer In silicodetection for 12 additional cancers, including pancreaticMore than 2,600 proprietary biomarker panels Rapidly expanding to other cancers and diseases Innovative biotechnology firm with promising pancreatic cancer results projected to begin human studies for several challenging solid tumors by mid-2024Combination creates potential multiplier...
Nasdaq GlobeNewswire
09/08/2023

Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5…

The report said: "North America is expected to retain the leading position in the global pharmaceuticals market with market share of 45.33% in 2023. Asia Pacific pharmaceuticals market is expected to retain the second position with a market share of 24.07% in 2023. Europe on the contrary is expected to see a decline in the market share and will be worth 20.24% of global pharma industry in 2023. Latin America & Middle East and Africa (MEA) combined is expected to retain 7.53% and 2.96%…
PR Newswire
09/08/2023

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 9August 2023– On 9 May 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 30 billion to be executed during a 12-month period beginning 1 February 2023. Under the...
Nasdaq GlobeNewswire
09/08/2023

Antion Welcomes John Tchelingerian as Chairman of the Board

New Board Chairman appointed to position Antion for its next phase of growth and development As part of this organizational restructure, the Board includes the valuable financial and commercial insights of Mr. Boudewijn van Vliet, the previous Chairman, and Mr. Dan Hunt, as representative of Allogene Therapeutics, alongside the foundational know-how of the company's scientific founders, Professors Michael Pepper and Roberto Speck.In light of these changes, Mr. Boudewijn van Vliet, the...
Nasdaq GlobeNewswire
09/08/2023

Maypharm Launches SEDY FILL, a hyaluronic acid body filler

SEDY FILL has become one of the most preferred and widely used synthetic fillers in the world despite all the products available on the market. The reason is that SEDY FILL has been improved over time to enhance the breasts and buttocks, even with implants, fat grafting, and other injectable fillers. SEDY FILL has become one of the most preferred and widely used synthetic fillers in the world despite all the products available on the market. The reason is that SEDY FILL has been...
PR Newswire
09/08/2023

Asia Pacific Pharmacy Automation Market worth $763 million | MarketsandMarkets

The increasing awareness among pharmacists, healthcare cost-reduction measures, and significant growth potential in emerging markets are some of the key factors that offer opportunities to the market during the forecast period. However, the stringent regulatory procedures, and the risk of cross-contamination are some of the factors challenging the market growth to some extent. The increasing awareness among pharmacists, healthcare cost-reduction measures, and significant growth potential in...
PR Newswire
09/08/2023

Nutraceutical Packaging Market worth $4.2 billion by 2028 - Exclusive Report by…

Browse in-depth TOC on "Nutraceutical Packaging Market" Browse in-depth TOC on "Nutraceutical Packaging Market" 161 – Tables 45 – Figures 225 – Pages Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=15284853 "Blisters and Strips segment is projected to be the second largest segment by packaging type, in terms of value, during the forecast period." Blisters & Strips is the second largest packaging segment in the nutraceutical…
PR Newswire
09/08/2023
Altri  Comunicati